{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T19:02:43Z","timestamp":1743534163897},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1097\/pcc.0000000000002500","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:33:52Z","timestamp":1601512432000},"page":"926-927","source":"Crossref","is-referenced-by-count":2,"title":["Noninvasive Surfactant Use in the Treatment of Respiratory Distress Syndrome"],"prefix":"10.1097","volume":"21","author":[{"given":"Yasmin M.","family":"Madney","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio M.","family":"Esquinas","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Hospital M. Meseguer, Murcia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitham","family":"Saeed","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadeer S.","family":"Harb","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed E.A.","family":"Abdelrahim","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,10,1]]},"reference":[{"key":"R1-20230823","doi-asserted-by":"crossref","first-page":"e560","DOI":"10.1542\/peds.113.6.e560","article-title":"Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants <30 weeks\u2019 gestation.","volume":"113","author":"Dani","year":"2004","journal-title":"Pediatrics"},{"key":"R2-20230823","doi-asserted-by":"crossref","first-page":"e456","DOI":"10.1097\/PCC.0000000000002313","article-title":"Dose-Response Study on Surfactant Nebulization Therapy During Nasal Continuous Positive Airway Pressure Ventilation in Spontaneously Breathing Surfactant-Deficient Newborn Piglets.","volume":"21","author":"Rey-Santano","year":"2020","journal-title":"Pediatr Crit Care Med"},{"key":"R3-20230823","doi-asserted-by":"crossref","first-page":"F17","DOI":"10.1136\/archdischild-2015-310299","article-title":"Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: A systematic review and meta-analysis.","volume":"102","author":"Aldana-Aguirre","year":"2017","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R4-20230823","doi-asserted-by":"crossref","first-page":"L917","DOI":"10.1152\/ajplung.00207.2011","article-title":"Injury and repair in the very immature lung following brief mechanical ventilation.","volume":"301","author":"Brew","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R5-20230823","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s001340050459","article-title":"Surfactant nebulisation prevents the adverse effects of surfactant therapy on blood pressure and cerebral blood flow in rabbits with severe respiratory failure.","volume":"23","author":"Dijk","year":"1997","journal-title":"Intensive Care Med"},{"key":"R6-20230823","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-2004-823779","article-title":"A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants.","volume":"21","author":"Ramanathan","year":"2004","journal-title":"Am J Perinatol"},{"key":"R7-20230823","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1159\/000458466","article-title":"Surfactant for respiratory distress syndrome: New ideas on a familiar drug with innovative applications.","volume":"111","author":"Niemarkt","year":"2017","journal-title":"Neonatology"},{"key":"R8-20230823","doi-asserted-by":"crossref","first-page":"F313","DOI":"10.1136\/archdischild-2018-315051","article-title":"Nebulised surfactant to reduce severity of respiratory distress: A blinded, parallel, randomised controlled trial.","volume":"104","author":"Minocchieri","year":"2019","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R9-20230823","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1542\/peds.2013-3443","article-title":"Surfactant replacement therapy for preterm and term neonates with respiratory distress.","volume":"133","author":"Polin","year":"2014","journal-title":"Pediatrics"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000002500","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:50:58Z","timestamp":1692838258000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000002500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":9,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000002500","relation":{},"ISSN":["1529-7535"],"issn-type":[{"value":"1529-7535","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]}}}